김동연 / Ph.D.
게시글 작성정보
- 작성자 분자영상테라노스틱스연구소
- 작성일 17-12-11 16:35
- 조회수 1,233
- 댓글수 0
게시글 본문
기본정보
| 사진 |
 |
|---|---|
| 직책 | 조교수, 경상국립대학교 약학대학 |
| 관심연구분야 | 방사성의약품개발, 분자영상, 방사성동위원소 표지 |
| 이메일 | blueburr@gmail.com |
| 교육 | - 2018 : 겸임조교수, 전남대학교 의과대학, 화순전남대학교병원 핵의학과 - 2012 - 2017: 박사후 연구원, 화순전남대학교병원 핵의학과 - 2007 - 2012: 연구직, 화순전남대학교병원 핵의학과 - 2008 - 2012: 동국대학교(서울) 이과대학 화학과 박사 - 2006 - 2008: 동국대학교(서울) 이과대학 화학과 석사 - 1999 - 2006: 동국대학교(서울) 이과대학 화학과 학사 |
| 경력 | - 2017 - 현재: 연구직 4급 화순전남대학교 병원 핵의학과 - 2013 - 2017: 연구직 5급 화순전남대학교 병원 핵의학과 - 2009 - 2013: 연구직 6급 화순전남대학교 병원 핵의학과 - 2007 - 2009: 연구직 (통상근무) 화순전남대학교 병원 핵의학과 |
| 수상경력 | - Alavi-Mandell Award, Society of Nuclear Medicine and Molecular Imaging (2016) - Young Investigator Award, The China, Japan, Korea Conference on Nuclear Medicine and The Korea Society of Nuclear Medicine (2013) - Asian Young Investigator Award, The Japanese Society of Nuclear Medicine (2013) - Travel Scholarship, The World Molecular Imaging Congress (2012) - Cardiovascular Council Basic Science Young Investigator Award Second Place, The Society of Nuclear Medicine (2011) - Young Investigator Award Travel Grant, The Society of Nuclear Medicine (2011) - Young Investigator’s Award, Korean Society of Molecular Imaging (2010) - Travel Scholarship, The World Molecular Imaging Congress (2010) |
| 학회 활동 | - 2017- Present: 방사성의약품 위원회 위원, 대한핵의학회 - 2014 - Present: 편집위원, 대한핵의학회 - 2013 - Present: 정회원, 대한핵의학회 - 2011 - Present: 정회원, Society of Nuclear Medicine and Molecular Imaging - 2010 - Present: 정회원, World Molecular Imaging Congress - 2010 - Present: 정회원, 대한분자영상학회 |
| 대표 연구업적 | -64Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor Expressing Tumors. J Nucl Med. 2017. Article in Press (2016 IF: 6.646, Corresponding Author) - Small bowel metastasis from hepatocellular carcinoma detected by F-18 FDG PET/CT but not by C-11 acetate PET/CT. Clinical Nuclear Medicine. 2017 Article in Press (2016 IF: 4.563, Co-author) - Potential visualization of sorafenib-induced acidosis using 11-C-acetate positron emission tomographycComputed Tomography in Patients with Hepatocellular Carcinoma. Clinical Nuclear Medicine. 2017 Article in Press (2016 IF: 4.563, Co-author) - Engineering of monobody conjugates for human EphA2-specific optical imaging. PLoS ONE. 2017 12(7): e0180786 (2016 IF: 2.806, Co-author) - Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected -11C-methionine uptake. EJNMMI Research. 2017; 7: 45 (2016 IF: 2.033, Co-author) - A high-affinity repebody for molecular imaging of EGFR-expressing malignant tumors. Theranostics. 2017; 7: 2620-2633 (2016 IF: 8.712, First author) - Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP. Ann Nucl Med. 2017; 31: 469-479 (2016 IF: 1.396, Co-author) - Comparison of reconstruction methods in a small animal cardiac PET study using a 18F-labeled myocardial agent, [18 F]FPTP. Iranian Journal of Radiology. 2017; 14(1)e26806 (2016 IF: 0.554, Corresponding Author) - Prognostic value of post-treatment metabolic tumor volume from 11 C-methionine PET/CT in recurrent malignant glioma. Neurosurg Rev. 2017; 40: 223-229 (2016 IF: 2.060, Co-author) - RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy. Theranostics. 2016; 6; 1672-1682 (2016 IF: 8.712, Co-author) - Radiolabeled Phosphonium Salts as Mitochondrial Voltage Sensors for Positron Emission Tomography Myocardial Imaging Agents. Nucl Med Mol Imaging. 2016; 50; 185-195 (Corresponding Author) - Comparison of 18 F-labeled fluoroalkylphosphonium cations with 13 N-NH3 for PET myocardial perfusion imaging. J Nucl Med. 2015; 56; 1581-1586 (2016 IF: 6.646, First author) - Isolation and characterization of a monobody with a fibronectin domain III scaffold that specifically binds EphA2. PLoS ONE. 2015 10(7): e0132976 (2016 IF: 2.806, Co-author) - Radiosynthesis and evaluation of 18 F-labeled aliphatic phosphonium cations as a myocardial imaging agent for positron emission tomography. Nuclear Medicine Communications. 2015; 36; 747-754 (2016 IF: 1.472, First author) - Synthesis and evaluation of 18 F-labeled fluoroalkyl triphenylphosphonium salts as mitochondrial voltage sensors in PET myocardial imaging. Methods in Molecular Biology. 2015; 1265; 59-72, (First author) - Synthesis and evaluation of 18 F-labeled pyrido[3,2-b]pyrazine derivative as a potential imaging agent for non-small-cell lung cancer. Bulletin of the Korean Chemical Society. 2015 ; 36 ;1778-1783 (2016 IF: 0.602, Co-author) - In-house development of an optimized synthetic module for routine [11 C]acetate production. Nuclear Medicine Communications. 2015; 36; 102–106 (2016 IF: 1.472, Corresponding Author) - Comparison of the cardiac microPET images obtained using [18 F]FPTP and [13N]NH3 in rat myocardial infarction. ACS Med. Chem. Lett. 2014; 5; 1124-1128 (2016 IF: 3.746, First author) - Development of the [11C] Acetate Synthesis Module. Journal of the Korean Physical Society. 2013; 63(7); 1390-1394 (2016 IF: 0.467, Co-author) - Evaluation of a mitochondrial voltage sensor, (18F-fluoropentyl)triphenylphosphonium cation, in a rat myocardial infarction model. J. Nucl. Med. 2012; 53:1779-1785 (2016 IF: 6.646, First author) - Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)tris(4-methoxyphenyl)phosphonium cation as a potential agent for positron emission tomography myocardial imaging. Nuclear Medicine and Biology. 2012; 39; 1093–1098 (2016 IF: 2.426, First author) - Synthesis of [18F]-labeled (6-fluorohexyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography. Bioconjugate Chem. 2012; 23; 431-437. (2016 IF: 4.818, First author) - Synthesis of [18F]-labeled (2-(2-fluoroethoxy)ethyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography. Bioorg. Med. Chem. Lett. 2012; 22; 319–322. (2016 IF: 2.454, First author) - Synthesis and characterization of a 68Ga-labeled N-(2-diethylaminoethyl)benzamide derivative as potential PET Probe for malignant melanoma. Bioorg. Med. Chem. 2012; 20; 4915–4920. (2016 IF: 2.930, Co-author) - Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging. Bioorg. Med. Chem. Lett. 2012; 22; 5288–5292 (2016 IF: 2.454, Co-author) |
첨부파일
1개-
이전글